Wall Street Zen downgraded shares of Healthpeak Properties (NYSE:DOC - Free Report) from a hold rating to a sell rating in a report issued on Monday.
Other research analysts also recently issued research reports about the company. Argus restated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Scotiabank decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday, May 12th. Evercore ISI dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Wells Fargo & Company reduced their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Finally, Wedbush lowered their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.27.
Check Out Our Latest Analysis on DOC
Healthpeak Properties Stock Down 1.4%
NYSE DOC traded down $0.25 during trading hours on Monday, hitting $17.97. The company's stock had a trading volume of 6,443,199 shares, compared to its average volume of 5,740,650. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01. The company's 50-day simple moving average is $17.42 and its two-hundred day simple moving average is $19.02. The company has a market capitalization of $12.48 billion, a PE ratio of 44.93, a price-to-earnings-growth ratio of 2.08 and a beta of 1.03. Healthpeak Properties has a 52 week low of $16.64 and a 52 week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the previous year, the firm earned $0.45 earnings per share. Healthpeak Properties's quarterly revenue was up 15.9% on a year-over-year basis. Research analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently announced a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. This represents a yield of 7.05%. The ex-dividend date was Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.
Insider Buying and Selling at Healthpeak Properties
In other Healthpeak Properties news, Director John T. Thomas bought 4,200 shares of the firm's stock in a transaction on Monday, April 28th. The shares were acquired at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the purchase, the director directly owned 813,566 shares of the company's stock, valued at $14,514,017.44. The trade was a 0.52% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Tommy G. Thompson acquired 5,777 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares of the company's stock, valued at $2,491,888.30. The trade was a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 29,764 shares of company stock valued at $521,909 in the last three months. Company insiders own 0.23% of the company's stock.
Institutional Trading of Healthpeak Properties
Large investors have recently bought and sold shares of the company. Invesco Ltd. boosted its stake in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Healthpeak Properties by 6.5% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust's stock worth $372,004,000 after acquiring an additional 1,129,924 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Healthpeak Properties by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust's stock valued at $371,168,000 after purchasing an additional 638,012 shares during the period. Centersquare Investment Management LLC increased its holdings in shares of Healthpeak Properties by 18.5% in the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock valued at $268,642,000 after acquiring an additional 2,070,416 shares during the period. Finally, Northern Trust Corp boosted its stake in Healthpeak Properties by 32.6% in the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock valued at $213,367,000 after acquiring an additional 2,590,530 shares in the last quarter. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report